Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Zepbound
Zepbound
GLP-1 drugs are driving up healthcare costs
Medical Marketing and Media
Fri, 07/26/24 - 11:03 am
obesity
weight loss
GLP-1 agonist
healthcare costs
Eli Lily
Novo Nordisk
Wegovy
Zepbound
NC Medicaid to cover weight-loss drugs like Wegovy, after access cut for state workers
Yahoo/Raleigh News & Observer
Mon, 07/22/24 - 06:48 pm
Novo Nordisk
Eli Lilly
obesity
Wegovy
Zepbound
North Carolina
Medicaid
Will Eli Lilly overtake Novo Nordisk in weight-loss drug race?
BioSpace
Tue, 07/16/24 - 12:11 pm
Eli Lilly
Novo Nordisk
Wegovy
Zepbound
weight loss
Patients on weight-loss drugs should inform doctor before surgery, EU regulator says
Reuters
Fri, 07/12/24 - 11:16 am
EMA
Novo Nordisk
Ozempic
Wegovy
Eli Lilly
Mounjaro
Zepbound
surgery
House committee backs some Medicare cover for obesity drugs
Pharmaphorum
Fri, 06/28/24 - 11:13 am
legislation
Medicare
obesity
Wegovy
Zepbound
House panel proposes new strategy for Medicare to cover weight loss drugs Wegovy, Zepbound
Stat
Thu, 06/27/24 - 11:13 am
Novo Nordisk
Medicare
Wegovy
Zepbound
Eli Lilly
legislation
Lilly Sees Path for Zepbound’s Label Expansion With Phase III Sleep Apnea Win
BioSpace
Mon, 06/24/24 - 11:20 am
Eli Lilly
Zepbound
clinical trials
sleep apnea
Employer coverage for weight-loss drugs rises sharply, survey finds
Reuters
Thu, 06/13/24 - 11:05 pm
insurance
weight loss
obesity
Eli Lilly
Novo Nordisk
Wegovy
Zepbound
Eli Lilly exec says seeing out of pocket payments for obesity drug in US
Reuters
Mon, 06/10/24 - 06:06 pm
Eli Lilly
Zepbound
Mounjaro
patients
obesity
diabetes
Added health benefits of Wegovy, Zepbound could attract more men, doctors say
Reuters
Mon, 06/10/24 - 11:15 am
Novo Nordisk
Wegovy
Eli Lilly
Zepbound
men's health
sleep apnea
heart disease
Weight loss drugs are so hard to find that this company built a tracker
Axios
Thu, 05/30/24 - 11:09 pm
Novo Nordisk
Eli Lilly
Wegovy
Zepbound
weight loss
obesity
drug shortages
Ro
Regeneron, Lilly grapple with clinical endpoints as obesity space moves to improving weight loss
Fierce Biotech
Thu, 05/2/24 - 10:14 pm
Regeneron
Eli Lilly
Zepbound
obesity
trevogrumab
bimagrumab
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
Yahoo Finance
Tue, 04/30/24 - 08:56 am
Novo Nordisk
Eli Lilly
earnings
obesity
weight loss
GLP-1 agonist
Ozempic
Wegovy
Zepbound
Mounjaro
Why the obesity drug market is about to get a lot more crowded
Medical Marketing and Media
Fri, 04/26/24 - 11:49 am
obesity
Novo Nordisk
Wegovy
Eli Lilly
Zepbound
Roche
AstraZeneca
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market
Motley Fool
Wed, 04/24/24 - 08:43 am
Eli Lilly
weight loss
Zepbound
Lilly to buy injectable drug plant in manufacturing ramp-up
BioPharma Dive
Mon, 04/22/24 - 05:54 pm
Eli Lilly
drug manufacturing
Mounjaro
Zepbound
Wisconsin
Drugs Like Ozempic And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are Looking At
Forbes
Thu, 04/18/24 - 10:25 pm
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Zepbound
Mounjaro
anxiety
addiction
heart disease
liver disease
Lilly eyes Zepbound label expansion after clearing phase III sleep apnea study
BioSpace
Wed, 04/17/24 - 11:32 am
Eli Lilly
Zepbound
sleep apnea
Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says
Reuters
Wed, 04/17/24 - 11:21 am
drug shortages
Eli Lilly
Zepbound
Mounjaro
diabetes
weight loss
Could Viking Therapeutics Become the Next Eli Lilly?
Motley Fool
Fri, 03/22/24 - 09:27 am
Viking Therapeutics
Eli Lilly
weight loss
VK-2735
Zepbound
Mounjaro
Pages
1
2
3
next ›
last »